Skip to main content
HR 790 114th Congress House Health Business records Civil actions and liability Drug safety, medical device, and laboratory regulation Drug therapy Health technology, devices, supplies Long-term, rehabilitative, and terminal care Prescription drugs Retail and wholesale trades Trade restrictions

Compassionate Freedom of Choice Act of 2015

Introduced: February 5, 2015 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 6, 2015
Referred to the Subcommittee on Health.
Feb 5, 2015
Referred to the House Committee on Energy and Commerce.
Feb 5, 2015
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Compassionate Freedom of Choice Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act prevents or restricts, and the Food and Drug Administration (FDA) must not prevent or restrict, the manufacture, importation, distribution, or sale of investigational drugs or devices for terminally ill patients.

The FDA is prohibited from requiring the disclosure, collection, or reporting of certain information concerning such drugs or devices, except that the sponsor of a clinical trial may voluntarily disclose, collect, or report such information to the FDA.

Except in cases of gross negligence or willful misconduct, any person who manufactures, imports, distributes, prescribes, or administers an investigational drug or device is not liable under state or federal law for loss, damage, or injury from: (1) the development, testing, production, acquisition, or use of such drugs or devices; or (2) their safety or effectiveness.

What's happening now February 6, 2015

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 790: Compassionate Freedom of Choice Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-HR-790/
MLA
"H.R. 790: Compassionate Freedom of Choice Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-790/.
Bluebook (legal)
H.R. 790, 114th Cong. (2026), https://openamerica.io/bill/114-HR-790/.
Markdown link
[H.R. 790: Compassionate Freedom of Choice Act of 2015](https://openamerica.io/bill/114-HR-790/)
Report a problem